Cocaine dependence is a complex neuropsychiatric disorder that is highly comorbid with other psychiatric traits. Association studies suggest that common genetic variants contribute substantially to cocaine dependence susceptibility. Also, increasing evidence supports the role of shared genetic risk factors in the lifetime co-occurrence of psychiatric traits and cocaine dependence. Here we performed a genome-wide association study (GWAS) meta-analysis of cocaine dependence using four different dbGaP datasets (2,085 cases and 4,293 controls).
Introduction
Cocaine is one of the most used illicit drugs worldwide and its abuse produces serious health problems. In Europe, around 5.2% of adults (from 15 to 64 years old) have tried cocaine (EMCDDA 2017) , but at most 20% will develop addiction (Wagner & Anthony 2002) . Cocaine dependence prevalence in the European population can be estimated around 1.1%, similar to the prevalence observed in American populations (Compton et al. 2007 ).
Cocaine dependence is a complex psychiatric disorder that results from the interaction of environmental and genetic risk factors. It is one of the most heritable psychiatric conditions, with an estimated heritability around 65-79% (Ducci & Goldman 2012) . Although many casecontrol association studies in candidate genes have been performed, only a few risk variants for cocaine dependence have been identified and replicated so far, such as rs16969968 in the CHRNA5 gene and rs806368 in CNR1 (Bühler et al. 2015) . To date, only one genome-wide association study (GWAS) on cocaine dependence has been performed in European-and African-American individuals (Gelernter et al. 2014) . When combining the two populations, one genomewide finding was identified in the FAM53B gene, using a symptom count approach, but this hit could not be replicated in a subsequent study (Pineda-Cirera et al. 2018) .
Several studies have shown that substance use disorders (SUD), and especially cocaine dependence, is highly comorbid with other psychiatric disorders and related phenotypes like aggressive, antisocial or risk-taking behaviors (Bezinović & Malatestinić 2009; Hasin & Kilcoyne 2012) . For example, the occurrence of lifetime SUD in patients with schizophrenia (SCZ) is 70-80%, in attention deficit/hyperactivity disorder (ADHD) it is 39.2% and in major depressive disorder (MDD) it is 16.1% (Currie et al. 2005; Westermeyer 2006; Piñeiro-Dieguez et al. 2016) .
Conversely, about 81% of substance abuse/dependence patients have at least one comorbid mental disorder: 33% MDD, 11% SCZ and 9% personality disorders (Shantna et al. 2009 ). Such comorbidity is associated with an increase of severity for all disorders, although it is unclear whether this relationship is causal or the result of shared genetic and/or environmental risk factors. Some studies have started to inspect these relationships using both genetic correlation and polygenic risk score approaches, supporting the hypothesized role of shared genetic risk factors in the lifetime co-occurrence of several psychiatric disorders and SUD (Carey et al. 2016; Hartz et al. 2017; Du Rietz et al. 2017; Reginsson et al. 2018 ).
Here we performed a GWAS meta-analysis of cocaine dependence in samples with European ancestry using datasets from the dbGaP repository. Then we investigated the shared genetics between cocaine dependence and other psychiatric traits.
Materials and methods
Detailed description of the materials and methods used, as well as supplementary figures, can be found in the Supplementary Information.
Subjects
The case-control GWAS meta-analysis was performed using four datasets from the dbGaP repository (https://www.ncbi.nlm.nih.gov/gap) under the project 17170 (Table 1 ). All cases used met DSM-IV criteria for cocaine dependence, although most of them are also dependent to other drugs of abuse. Drug abuse or dependence were discarded only in controls of the SAGE sample, whereas in the other studies general population individuals were used as controls.
Since samples 2-4 did not have enough controls to perform the association studies, we used controls from other datasets but genotyped with the same array and built using the same genome assembly. In all cases, patients and controls were from the same geographic area. In order to reduce bias, we merged controls with cases prior to quality control (QC) and imputation (Mitchell et al. 2014 ) (see Supplementary Information for detailed description of subjects used in this study).
The study was approved by the ethics committee of our institution, in accordance with the Helsinki Declaration and with the dbGaP protocols.
Quality control and association analyses
Prior to analysis, stringent QC was performed on the genotyped markers and individuals in each sample using the standardized pipeline "Ricopili" . European ancestry individuals were selected based on principal component analysis (PCA): PC1 and PC2 were used to define a genetic homogenous population, excluding individuals with PC values greater than three standard deviations from the reference population (European individuals from 1000 Genomes Project Phase 3 (1KGP3)). Related individuals and genetic outliers were excluded. A permutation test for between-group IBS differences with fixed 10,000 permutations was performed to discard population stratification between cases and controls.
After QC, non-genotyped markers were imputed using the European individuals from the 1KGP3 reference panel in MINIMAC3 (https://genome.sph.umich.edu/wiki/Minimac3).
For each sample, case-control GWAS was conducted using logistic regression under the additive model in PLINK v1.9 (http://pngu.mgh.harvard.edu/purcell/plink/). The 10 firsts PCs were included as covariates to correct for population stratification, and only variants with imputation INFO score >0.8 and minor allele frequency (MAF) >0.01 were considered.
GWAS meta-analysis
In total, 2,085 cases and 4,293 controls were meta-analyzed using an inverse-variance weighted fixed effects model in METAL (http://csg.sph.umich.edu//abecasis/Metal/) (Willer, Li, & Abecasis 2010) . Association results were considered only for variants with an effective sample size [N=2/((1/Ncases)+(1/Ncontrols))] greater than 70% of the full meta-analysis. Heterogeneity across studies was tested with the Cochran's Q test and quantified with the I 2 heterogeneity index, implemented in METAL.
Manhattan plot and Q-Q plot from each sample and the meta-analysis results were generated with the library "qqman" implemented in R.
LD Score intercept evaluation
LD score (LDSC) regression analysis was used to calculate LDSC intercept by regressing the chisquare statistics from GWAS against LD scores for each SNP (downloaded from GitHub website, https://github.com/bulik/ldsc) (Bulik-Sullivan et al. 2015b ).
SNP heritability LDSC 1.0.0 (https://github.com/bulik/ldsc/) was used to assess the proportion of phenotypic variance explained by common SNPs in the liability-scale, using a population prevalence for cocaine dependence of 1.1% (Compton et al. 2007 ).
Partitioned heritability analysis was performed based on 24 functional overlapping annotations described previously (Finucane et al. 2015) . Enrichment in the heritability of a functional category was defined as the proportion of SNP heritability explained divided by the proportion of SNPs. Additionally, we performed a heritability analysis based on the cell type-specific regulatory element H3K4me3, highly associated to promoters Woo et al. 2017) , from the Roadmap Epigenomic Mapping Consortium (Kundaje et al. 2015; Ernst & Kellis 2015) . The threshold for significance was calculated using the Bonferroni correction for multiple testing (P<2e-03 for partitioned heritability and P<5.6-e-04 for cell type-specific analysis).
Functional annotation of risk SNPs
SNPs were functionally annotated using FUMA (http://fuma.ctglab.nl/) (Watanabe et al. 2017) .
FUMA define lead SNPs as signals that are significantly associated with the phenotype of interest (we considered suggestive associations (P<1e-05)) and independent to each other (r 2 <0.1)). For each lead SNP, a "Genomic risk locus" is defined, including all independent signals that are physically close or overlapping in a single locus. The variants located in a "Genomic risk locus"
were explored considering the following functional annotations: eQTL (from GTEx v6/v7 and BRAINEAC), CADD_v1.3, ANNOVAR, RegulomeDB_v1.1, 15-core chromatin state and GWAScatalog e91.
Gene-based and gene-set association analyses
Gene-based and gene-set association analyses were performed with MAGMA 1.05b (Willer et al. 2010 ) using the summary statistics from the cocaine dependence GWAs meta-analysis. For gene-based analysis, the SNP-wise mean model was used as the statistic test, considering pvalues for SNPs located within the transcribed region. For multiple testing corrections, 10% FDR was considered.
Gene-set analysis was used to test for enrichment in association signals in genes belonging to specific biological pathways or processes. We performed a competitive test using: "All Canonical
Pathways" (1329 gene sets), "GO" (4436 gene sets) and "BioCarta" (217 gene sets) provided by MsigDB 5.1 (https://software.broadinstitute.org/gsea/msigdb/) (Subramanian et al. 2005) .
Multiple testing corrections were applied to each gene set separately. When gene sets are strongly overlapping, the Bonferroni correction can be quite conservative, and for that reason, we used an empirical multiple testing correction implemented in MAGMA, based on a permutation procedure.
Shared genetic factors between cocaine dependence and comorbid conditions Subjects
We studied shared genetic factors between cocaine dependence and six previously described comorbid conditions using publicly available GWAS summary statistics of SCZ, ADHD, MDD, children's aggressive behavior, antisocial behavior and risk-taking behavior (Table 2 ). Summary statistics from the vitamin D levels GWAS of the UK Biobank was used as a negative control.
LDSC Genetic correlation
Genetic correlation between cocaine dependence and the six selected comorbid disorders/traits was calculated using LDSC 1.0.0 (Bulik-Sullivan et al. 2015a) . Summary statistics from all samples and pre-computed LD scores from HapMap3_SNPs calculated on 378 phased European-ancestry individuals from 1KGP3 were used (available at https://github.com/buligk/ldsc). After
Bonferroni correction, the significance threshold was adjusted to P<7.1e-03.
Furthermore, the genetic correlation of cocaine dependence with other traits available at LD Hub (http://ldsc.broadinstitute.org/ldhub/) (Zheng et al. 2017 ) was evaluated (Bonferroni correction threshold P<7.2e-05).
Polygenic risk scores for cocaine dependence
Poligenic risk score (PRS) analysis was performed using the PRSice 2.1.0 software (https://github.com/choishingwan/PRSice) (Euesden, Lewis, & O'Reilly 2015) .
The four cocaine dependence datasets were merged using PLINK v1.9 and used as a target sample. After merging, strict QC was applied resulting in 5,957,307 SNPs in 2,083 cases and 4,287 controls. To assess population stratification PCA was performed, and the 10 first PCs and a dummy variable indicating genotyping-study was included in the PRS analysis as a covariate.
Summary statistics of the seven phenotypes described above were used as discovery samples, which were clumped (r 2 <0.1 in a 250-kb window) to remove SNPs in LD. Then, PRSs were estimated for each discovery sample using a wild range of meta-analysis p-value thresholds (P T ) between P T =1e-04 and P T =1 at increments of 5e-05. For each P T , the proportion of variance explained (R 2 ) by each discovery sample was computed by comparing the full model (PRS + covariates) score to a reduced model (covariates only). The reported R 2 value is the difference between R 2 from the two models. For quantitative traits we performed linear regression analysis, and for qualitative traits we used logistic regression and Nagelkerke's pseudo-R 2 values are shown.
As recommended, we used the significance threshold of P=0.004 (Euesden et al. 2015) .
Bonferroni correction was applied considering the seven tested phenotypes (P<5.7e-04).
Gene-based meta-analysis with comorbid conditions
Six independent gene-based meta-analyses were performed between cocaine dependence and the six phenotypes previously described using MAGMA 1.05b. Gene-based analysis of each independent dataset was performed as previously described. Then, the weighted Stouffer's Z method was used to combine the Z-scores for each gene across cohorts, with weights set to the square root of the sample size. Signification threshold was calculated using the Bonferroni correction to control for multiple testing (P<2.8e-06).
Results

GWAS results
We performed a GWAS meta-analysis of cocaine dependence using four datasets from the dbGaP repository. In total, we meta-analized 9,290,362 common genetic variants in 2,085 cases and 4,293 controls of European ancestry. No marker demonstrated significant heterogeneity between studies ( Figure S1 ). The Q-Q plot ( Figure 1A ) displayed a λ of 1.06, comparable to other GWAS. The LDSC analyses estimated an intercept of 1.01 (SE=0.006; P=0.1), not significantly greater than 1, indicating that most of the observed inflation can be attributed to polygenicity rather than to residual population stratification or cryptic relatedness (Bulik-Sullivan et al. 2015b ).
None of the analyzed variants reached the threshold for genome-wide significance (P<5e-08) in the SNP-based analysis, although we identified several suggestive associations (P<1e-05) (Table   S1 ; Figure 1B ).
Polygenic architecture of cocaine dependence
We applied LDSC analysis to assess the proportion of phenotypic variance explained by common Figure S2) . Furthermore, the analysis of the promoterassociated mark H3K4me3 in individual cells/tissues, revealed an enrichment in ten brain tissues and neuronal cell lines, although none of them overcame the Bonferroni correction for multiple testing ( Figure S3 ).
Functional annotation of risk SNPs
In order to identify potentially interesting regions, we performed functional annotation analyses with FUMA considering only SNPs showing suggestive associations. We identified 23 lead SNPs which correspond to 22 genomic risk loci including 112 genes (Table 3 ). The most interesting risk locus, located on chromosome 6, is defined by two lead SNPs (rs806973 and rs56401801, GWAs P=3.1e-06 and 3.4e-06, respectively) and it includes 77 genes and 458 nominally associated SNPs. Interestingly, most of the SNPs in this region (447) are brain eQTLs for at least one member of a small group of 12 genes, including BTN3A2, HIST1H2AK, ZSCAN31, PRSS16 and ZNF184 (Figure 2) . Also, it is important to notice that many SNPs in this region have a CADD score greater than 12.37, highlighting a deleterious effect, and a low RegulomeDB score, suggesting regulatory functionality (Figures 2 and S4 ). Another interesting region was identified on chromosome 1 defined by the lead SNP rs148069235 . This region includes 236 SNPs that cover six genes, and three of them (PLEKHM2, DDI2 and SLC25A34) have several brain eQTLs in this region ( Figure S5 ). Finally, another region on chromosome 13, defined by the lead SNP rs79309473 (GWAs P=1.8e-06), includes five genes and 26 nominally associated SNPs, many of them brain eQTLs for SOHLH2 ( Figure S6 ).
Gene-based and gene-set analyses
The gene-based analysis mapped 3,418,270 SNPs from the GWAS meta-analysis to 18,069 protein-coding genes ( Figure S7 and Table S2 ). The HIST1H2BD gene, located in the genomic region on chr6 showing a suggestive association in the SNP-based analysis, displayed a significant gene-wise association with cocaine dependence (surpassing 10% FDR), although it did not overcome the Bonferroni correction for multiple testing. Then we performed competitive gene-set tests for all BioCarta, GO and Canonical Pathways. No gene sets attained a significant associated with cocaine dependence after correction for multiple testing (Table S3- 
Cocaine dependence and shared genetic factors with comorbid conditions
Cocaine dependence is highly comorbid with other psychiatric disorders like SCZ, ADHD and MDD, and also with other phenotypes like aggressive behavior (Child-Aggre), antisocial behavior (ASB) or risk taking (RT). In order to investigate whether these phenotypic correlations are genetically mirrored, we performed a genetic correlation analysis using LDSC analysis and found significant genetic correlations (P<7.1e-03) between cocaine dependence and SCZ (rg=0. Figure 3A) . However, no significant genetic correlations were found with Child-Aggre or ASB, nor with a negative control (Vitamin D levels).
On the other hand, we tested genetic correlations between cocaine dependence and all the GWAS summary statistics publicly available in the LD Hub. From the 690 tested traits, 109 demonstrated significant correlations after applying the Bonferroni correction, including a negative correlation with educational achievement (e.g. college completion and intelligence) or with reproductive traits (e.g. age of the first birth and age starting oral contraceptive pills) and a positive correlation with familiar situation (e.g. being adopted as a child or tobacco smoke exposure at home) or with several psychological or psychiatric traits like neuroticism, depressive symptoms or loneliness ( Figure S8 and Table S6 ).
We also investigated the shared genetic etiology between cocaine dependence and comorbid phenotypes through PRS analysis, and tested whether these phenotypes can predict cocaine Figure 3B and S9) . In all cases, the quantile plot shows the positive nature of this relationship as cocaine dependence increases with greater polygenic load at each discovery dataset ( Figure S10 ). As expected, the negative control based on vitamin D levels did not predict cocaine dependence (R 2 =0.07%, P T =0.03075, P=0.06).
Gene-based meta-analysis with comorbid conditions
Finally, we performed a gene-based meta-analysis between cocaine dependence and each of the six comorbid phenotypes from the previous section in order to identify novel genes involved in each pair of disorders. However, the differences in the sample size of the different dataset pairs hampered this approach. The most interesting results were obtained when we combined cocaine dependence with ADHD. We found significant association with two new genes: AMIGO3
and BSN (combined P=4.24e-07 and 5.13e-07, respectively), and also with 19 of the 20 genes previously identified in a gene-based analysis performed as part of the ADHD meta-analysis by Demontis et al. (2017) . Four of these 19 associations increased significance by at least one order of magnitude in the combined analysis (TIE1, CDH8, ELOVL1 and CCDC24) ( Table S7 ).
The gene-based meta-analysis between cocaine dependence and SCZ revealed 360 associations:
28 new genes and 332 that were already highlighted in the SCZ study alone. However, all of the new findings were driven by the SCZ dataset. Three of the 332 genes increased the significance of the association by three orders of magnitude (BTN3A2, HIST1H2BD and SLC17A1), 15 genes by two orders of magnitude and 73 by one (Table S8) .
No relevant results were obtained in the gene-based meta-analysis of cocaine dependence with MDD, RT, ASB or Child-Aggre.
Discussion
To our knowledge, this is the largest GWAS meta-analysis on cocaine dependence performed to date in individuals with European ancestry. Although no genome-wide significant (GWS) hits were found, gene-based analysis identified HIST1H2BD as significantly associated with cocaine dependence. This gene is located in a region of chromosome 6 enriched in immune system and histone-related genes. Interestingly, immune and histone pathways have previously been associated with other psychiatric disorders like schizophrenia, major depressive disorder and bipolar disorder (O'Dushlaine et al. 2015) . Moreover, this region overlaps with the genomic region that has been most consistently associated with SCZ. Indeed, we found five SNPs in this region (rs16897515, rs17693963, rs34706883, rs41266839 and rs55834529) nominally associated with cocaine dependence (P<1e-04) that had previously been associated with schizophrenia and with bipolar disorder. The most relevant is rs17693963, reported in three different studies (Bergen et al. 2012; Sleiman et al. 2013; Ruderfer et al. 2014) (Sanders et al. 2013) .
Cocaine dependence is a highly heritable disorder (around 65-79% (Ducci & Goldman 2012) ).
The results from LDSC analysis showed that common SNPs significantly capture almost a half of the cocaine dependence heritability (h 2 SNP =0.3; P=2.4e-07). Similar results were obtained previously for alcohol dependence (Mbarek et al. 2015) and other psychiatric disorders (Lee et al. 2013) . Furthermore, the analysis of the promoter-associated mark H3K4me3 in individual cells/tissues Woo et al. 2017 ) highlighted a nominal enrichment of SNP heritability in brain tissues and neuronal cell lines. The highest enrichment was observed in substantia nigra, which plays an important role in reward and thus it may be related to the development of the dependence (Beaudoin et al. 2017) .
It is well known that most psychiatric disorders are highly comorbid. About 73.4% of cocaine abuse/dependence patients have comorbid mental disorders: 49.7% have personality disorders (e.g. 5.3% schizoid and 17% antisocial personality) and 61.5% other mental disorders (e.g. 23.4%
MDD and 20.5% anxiety) (Arias et al. 2013) . However, the reasons for these covariations remain largely unknown. We investigated whether the phenotypic correlations between cocaine dependence and six comorbid psychiatric traits are genetically mirrored by performing genetic correlation analysis using LDSC and, for the first time, we found significant genetic correlation with ADHD, SCZ, MDD and risk-taking behavior. Furthermore, we used the PRS method that, in contrast to LDSC, uses individual-level SNP data, resulting in greater statistical power and allowing for direct testing of interaction effects. According to our results, all the tested comorbid conditions can predict cocaine dependence status, suggesting that cocaine dependence is more probable in individuals with many risk alleles for the tested conditions than in those with fewer risk alleles. To our knowledge, this is the first report of a shared genetic etiology between cocaine dependence and ADHD, antisocial behavior, risk-taking behavior and children's aggressive behavior based on genome-wide data. Previous studies have reported significant PRS associations between cocaine dependence and SCZ or MDD (Carey et al. 2016; Hartz et al. 2017; Reginsson et al. 2018) , and also between SUD and other psychiatric disorders (Du Rietz et al. 2017; Gurriarán et al. 2018) , although our study used the largest sample of cocaine dependence for this type of analysis so far. This correlation can reflect biological pleiotropy, where similar genetic mechanisms influence more than one trait, or mediated pleiotropy, where one phenotype is causally related to a second phenotype, so that the variants associated with this phenotype are indirectly associated with the second one. Further studies are needed to identify the genetic pathways and neurobiological mechanisms underlying this genetic overlap.
Gene-based meta-analysis between different disorders allows identification of new genes involved at the same time in the different disorders considered. We performed this analysis for cocaine dependence with each of the comorbid conditions where genetic correlations were detected. The most interesting results were obtained when combining cocaine dependence and ADHD, identifying two new genes: AMIGO3 and BSN, both involved in brain function. AMIGO3 inhibits maturation of oligodendrocyte precursor cells and myelin production (Foale et al. 2017) .
BSN is a brain specific gene involved in the organization of the cytomatrix at the presynaptic active zone which regulates neurotransmitter release (Südhof 2004 ). Previously, we reported an association between another component of the neurotransmitter release machinery, NSF, and cocaine dependence (Fernàndez-Castillo et al. 2012; Cabana-Domínguez et al. 2016 ).
This study has strengths and limitations that need some discussion. We performed a GWAS meta-analysis using all the cocaine dependence datasets available in the dbGaP repository, but we could not find any GWS association at the SNP-based level, as expected given the limited sample size. However, these data allowed us to detect genetic correlations between cocaine dependence and several co-occurring conditions. Also, we calculated polygenic risk scores that explain a small fraction of the variance in the target phenotype. To obtain a more comprehensive picture of the etiological overlap between cocaine dependence and comorbid conditions, a larger sample will be needed, and other genetic factors should be included in the analysis (e.g.
CNVs and rare variants). On the other hand, some of the dbGaP datasets used included only cases but not control individuals. For this reason, we took controls from other datasets that can introduce potential biases into the experimental design. Nevertheless, we performed very strict quality controls to avoid population stratification: the paired case and control samples were genotyped with the same platform and come from the same geographical area, the merging of the different datasets was performed prior to quality control and imputation, and after that a permutation test was performed to discard population stratification (Mitchell et al. 2014 ).
Finally, the disease phenotype has not been excluded in most of the control samples, which may potentially dilute positive findings in the association study (but not lead to false positive results).
However, based on the prevalence of cocaine dependence (about 1.1%), the probability of false negative results due to this effect is low, and similar controls were used in other GWAS of drug addiction (Johnson et al. 2016 ).
In conclusion, we reported the largest cocaine dependence GWAS meta-analysis on individuals of European ancestry, even though no GWS hits could be identified. Increasing the number of individuals of this study would increase the chances to detect significant associations.
Furthermore, we found evidence for a shared genetic etiology between cocaine dependence and several comorbid conditions. Further studies are needed to identify the genetic pathways and neurobiological mechanisms that underlie this genetic overlap.
